Cargando…

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

OBJECTIVE: Individuals with Down syndrome (DS) have an extremely high genetic risk for Alzheimer's disease (AD), however, the course of cognitive decline associated with progression to dementia is ill‐defined. Data‐driven methods can estimate long‐term trends from cross‐sectional data while adj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Firth, Nicholas C., Startin, Carla M., Hithersay, Rosalyn, Hamburg, Sarah, Wijeratne, Peter A., Mok, Kin Y., Hardy, John, Alexander, Daniel C., Strydom, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989753/ https://www.ncbi.nlm.nih.gov/pubmed/29928657 http://dx.doi.org/10.1002/acn3.571

Ejemplares similares

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome
por: Pape, Sarah E., et al.
Publicado: (2021)

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2016)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
por: Hithersay, Rosalyn, et al.
Publicado: (2018)

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome
por: D’Souza, Hana, et al.
Publicado: (2020)

Health comorbidities and cognitive abilities across the lifespan in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2020)

Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)
por: Startin, Carla M., et al.
Publicado: (2016)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome
por: Saini, Fedal, et al.
Publicado: (2023)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome
por: Hamburg, Sarah, et al.
Publicado: (2019)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls
por: Hamburg, Sarah, et al.
Publicado: (2021)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

The importance of understanding individual differences in Down syndrome
por: Karmiloff-Smith, Annette, et al.
Publicado: (2016)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome()
por: Mok, Kin Y., et al.
Publicado: (2014)

Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2020)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2021)

Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome
por: Jones, Emma L., et al.
Publicado: (2013)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Predictors of Age of Diagnosis and Survival of Alzheimer’s Disease in Down Syndrome
por: Sinai, Amanda, et al.
Publicado: (2017)

Erratum to “Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome” [Neurobiol. Aging 35 (2014) 1513.e1–1513.e5]
por: Mok, Kin Y., et al.
Publicado: (2014)

Erratum to “Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome” [Neurobiol. Aging 35 (2014) 1513.e1–1513.e5]
por: Mok, Kin Y., et al.
Publicado: (2014)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Intracerebral haemorrhage in Down syndrome: protected or predisposed?
por: Buss, Lewis, et al.
Publicado: (2016)

Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB)
por: Sinai, Amanda, et al.
Publicado: (2016)

Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
por: Mann, David M. A., et al.
Publicado: (2018)

Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome
por: Videla, Laura, et al.
Publicado: (2022)

Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses
por: Alhajraf, Falah, et al.
Publicado: (2019)

Variation in the X-Linked EFHC2 Gene Is Associated with Social Cognitive Abilities in Males
por: Startin, Carla M., et al.
Publicado: (2015)

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018)

Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK
por: Baksh, R. Asaad, et al.
Publicado: (2022)

Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer’s Disease
por: Oxtoby, Neil P., et al.
Publicado: (2017)

Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records
por: Aslam, Aisha A., et al.
Publicado: (2022)

A multi-level developmental approach to exploring individual differences in Down syndrome: genes, brain, behaviour, and environment
por: Thomas, Michael S.C., et al.
Publicado: (2020)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Down with Retirement: Implications of Embodied Cognition for Healthy Aging
por: Hommel, Bernhard, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k3hild5lmrpsqum05ui6hjto9t